Cytokine Response in Dyslipoproteinemia in Adults Living in the European North of Russia Depending on Their Body Mass Index.
DOI:
https://doi.org/10.37482/2687-1491-Z139Keywords:
cytokines, cytokine response, inflammation, lipid profile, dysliporoteinemia, obesity, European North of RussiaAbstract
An increase in proinflammatory cytokine content in the blood is a stereotypical inflammatory response, regardless of the etiology or type of inflammation. Since cytokines exhibit pleiotropy, they serve as signalling molecules in intercellular interactions and stimulate the functional activity of cells, their proliferation and differentiation. The purpose of this study was to identify the frequency of elevated cytokine levels in dyslipoproteinemia in adults with different body weight living in the European North of Russia. Materials and methods. The study involved 313 residents of Arkhangelsk aged 45–60 years: with normal body weight (211 subjects; body mass index up to 30 kg/m2) and obesity (102 subjects; body mass index 31–40 kg/m2). The enzymatic and turbidimetric methods were applied to evaluate lipid profile parameters using an automatic biochemical analyser; cytokine levels were determined using solid-phase enzyme immunoassay. Results. In subjects with normal body weight, elevated blood concentrations of the cytokines under study coinciding with dyslipoproteinemia were detected in 2–11 % of cases. In obesity, elevated cytokine levels were 2–7 times more frequent; the sharpest differences were observed regarding IL-6, whose elevated concentrations reached 44 % of cases. A significant increase in IL-1ß concentrations in the blood of the subjects is associated with an increase in the levels of low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) as well as triglycerides (TG). The frequency of increased TNF-α levels was the most significant (36.28 %) at abnormally high TG concentrations.
Elevated IL-6 levels were most often associated with an increase in the blood concentration of several transport forms: LDL, VLDL, oxidized LDL, and TG. In over 40 % of cases, increased IL-10 was observed in the blood of individuals with abnormally high levels of LDL and VLDL. Thus, obese residents of the European North of Russia are characterized by a more pronounced cytokine response. At the same time, cytokine response (irrespective of the body mass) is primarily associated with an increase in the blood levels of LDL, VLDL and oxidized LDL.
Downloads
References
Le G., Novotny S.A., Mader T.L., Greising S.M., Chan S.S.K., Kyba M., Lowe D.A., Warren G.L. A Moderate Oestradiol Level Enhances Neutrophil Number and Activity in Muscle After Traumatic Injury but Strength Recovery Is Accelerated // J. Physiol. 2018. Vol. 596, № 19. Р. 4665–4680. DOI: 10.1113/JP276432
Князева Л.И., Шишова А.С., Степченко М.А. Динамика показателей иммунного статуса и ригидности сосудистой стенки у больных артериальной гипертензией с ожирением // Фундам. исследования. 2012. № 7-2. С. 338–343.
Giannakopoulou C.E., Sotiriou A., Dettoraki M., Yang M., Perlikos F., Toumpanakis D., Prezerakos G., Koutsourelakis I., Kastis G.A., Vassilakopoulou V., Mizi E., Papalois A., Greer J.J., Vassilakopoulos T. Regulation of Breathing Pattern by IL-10 // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2019. Vol. 317, № 1. Р. R190–R202. DOI: 10.1152/ajpregu.00065.2019
Steensberg A., Febbraio M.A., Osada T., Schjerling P., Hall G., Saltin B., Pedersen B.K. Interleukin-6 Production in Contracting Human Skeletal Muscle Is Influenced by Pre-Exercise Glycogen Content // J. Physiol. 2001. Vol. 537, № 2. P. 633–639. DOI: 10.1111/j.1469-7793.2001.00633.x
Snodgrass R.G., Boß M., Zezina E., Weigert A., Dehne N., Fleming I., Brüne B., Namgaladze D. Hypoxia Potentiates Palmitate-Induced Pro-Inflammatory Activation of Primary Human Macrophages // J. Biol. Chem. 2016. Vol. 291, № 1. P. 413–424. DOI: 10.1074/jbc.M115.686709
Катинас Е.Б. Рябова М.А., Карпищенко С.А. Цитокиновый состав ларингеального секрета у больных рецидивирующим папилломатозом гортани при местной терапии интерфероном альфа-2 // Рос. иммунол. журн. 2008. Т. 2(11), № 2. С. 186–196.
Van Snick J. Interleukin-6: An Overview // Annu. Rev. Immunol. 1990. Vol. 8. P. 253–278. DOI: 10.1146/annurev.iy.08.040190.001345
Schwartz E.A., Zhang W.-Y., Karnik S.K., Borwege S., Anand V.R., Laine P.S., Su Y., Reaven P.D. Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation // Arterioscler. Thromb. Vasc. Biol. 2010. Vol. 30, № 4. P. 802–808. DOI: 10.1161/ATVBAHA.109.201681
Титов В.Н., Рожкова Т.А., Каминная В.И. Роль избыточного количества мясной пищи в патогенезе атеросклероза и атероматоза у животных и человека (обзор) // Журн. мед.-биол. исследований. 2018. Т. 6, № 2. С. 174–187. DOI: 10.17238/issn2542-1298.2018.6.2.174
Титов В.Н., Крылин В.В., Ширяева Ю.К. Профилактика атеросклероза. Избыток в пище пальмитиновой кислоты – причина гиперхолестеринемии, синдрома воспаления, резистентности миоцитов к инсулину и апоптоза // Клин. лаб. диагностика. 2011. № 2. С. 4–15.
Cury-Boaventura M.F., Gorjão R., Martins de Lima T., Fiamoncini J., Godoy A.B.P., Deschamphs F.C., Soriano F.G., Curi R. Effect of Medium/ω-6 Long Chain Triglyceride-Based Emulsion on Leucocyte Death and Inflammatory Gene Expression // Clin. Exp. Immunol. 2011. Vol. 165, № 3. Р. 383–392. DOI: 10.1111/j.1365-2249.2011.04432.x
Ставинская О.А., Балашова С.Н. Участие лептина в регуляции программируемой клеточной гибели у лиц с дислипидемией // Экология человека. 2015. № 12. C. 34–37.
Diaconu A., Coculescu B.I., Manole G., Vultur H., Coculescu E.C., Stocheci C.M., Tudorache I.S., Dincă A.L., Dincă V.G. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) – Possible Diagnostic and Risk Biomarker in Chronic Ischaemic Heart Disease // J. Enzyme Inhib. Med. Chem. 2021. Vol. 36, № 1. P. 68–73. DOI: 10.1080/14756366.2020.1839447
Nezos A., Skarlis C., Psarrou A., Markakis K., Garantziotis P., Papanikolaou A., Gravani F., Voulgarelis M., Tzioufas A.G., Koutsilieris M., Moutsopoulos H.M., Kotsifaki E., Mavragani C.P. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma? // Front. Immunol. 2021. Vol. 12. Art. № 683623. DOI: 10.3389/fimmu.2021.683623
Yazdi A.S., Ghoreschi K. The Interleukin-1 Family // Adv. Exp. Med. Biol. 2016. Vol. 941. P. 21–29. DOI: 10.1007/978-94-024-0921-5_2
Shin M.S., Kang Y., Lee N., Wahl E.R., Kim S.H., Kang K.S., Lazova R., Kang I. Self Double-Stranded (ds)DNA Induces IL-1β Production from Human Monocytes by Activating NLRP3 Inflammasome in the Presence of Anti-dsDNA Antibodies // J. Immunol. 2013. Vol. 190, № 4. Р. 1407–1415. DOI: 10.4049/jimmunol.1201195
Snodgrass R.G., Huang S., Namgaladze D., Jandali O., Shao T., Sama S., Brüne B., Hwang D.H. Docosahexaenoic Acid and Palmitic Acid Reciprocally Modulate Monocyte Activation in Part Through Endoplasmic Reticulum Stress // J. Nutr. Biochem. 2016. Vol. 32. P. 39–45. DOI: 10.1016/j.jnutbio.2016.01.010
Данилова Г.А. Механизмы действия интерлейкина-1β на центральную хеморецепцию // XXII съезд Физиологического общества им. И.П. Павлова: тез. докл. Волгоград: Изд-во ВолгГМУ, 2013. С. 142–143.
Liu J., Cao L., Feng Y., Li Y., Li T. MiR-338-3p Inhibits TNF-α-Induced Lipogenesis in Human Sebocytes // Biotechnol. Lett. 2017. Vol. 39, № 9. Р. 1343–1349. DOI: 10.1007/s10529-017-2369-3
Montier Y., Lorentz A., Krämer S., Sellge G., Schock M., Bauer M., Schuppan D., Bischoff S.C. Central Role of IL-6 and MMP-1 for Cross Talk Between Human Intestinal Mast Cells and Human Intestinal Fibroblasts // Immunobiology. 2012. Vol. 217, № 9. Р. 912–919. DOI: 10.1016/j.imbio.2012.01.003
Ridker P.M., MacFadyen J.G., Glynn R.J., Bradwin G., Hasan A.A., Rifai N. Comparison of Interleukin-6, C-Reactive Protein, and Low-Density Lipoprotein Cholesterol as Biomarkers of Residual Risk in Contemporary Practice: Secondary Analyses from the Cardiovascular Inflammation Reduction Trial // Eur. Heart J. 2020. Vol. 41, № 31. P. 2952–2961. DOI: 10.1093/eurheartj/ehaa160
Señarís R.M., Trujillo M.L., Navia B., Comes G., Ferrer B., Giralt M., Hidalgo J. Interleukin-6 Regulates the Expression of Hypothalamic Neuropeptides Involved in Body Weight in a Gender-Dependent Way // J. Neuroendocrinol. 2011. Vol. 23, № 8. Р. 675–686. DOI: 10.1111/j.1365-2826.2011.02158.x
Самодова А.В., Добродеева Л.К., Штаборов В.А., Пашинская К.О. Влияние реакций мозгового натрийуретического пептида, ирисина, эндотелина 1 на состояние иммунной системы, работающих на архипелаге Шпицберген, в зависимости от срока проживания // Вестн. Кольск. науч. центра РАН. 2018. Т. 10, № 3. С. 87–92.
Wedell-Neergaard A.S., Lang Lehrskov L., Christensen R.H., Legaard G.E., Dorph E., Larsen M.K., Launbo N., Fagerlind S.R., Seide S.K., Nymand S., Ball M., Vinum N., Dahl C.N., Henneberg M., Ried-Larsen M., Nybing J.D., Christensen R., Rosenmeier J.B., Karstoft K., Pedersen B.K., Ellingsgaard H., Krogh-Madsen R. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial // Cell Metab. 2019. Vol. 29, № 4. P. 844–855. DOI: 10.1016/j.cmet.2018.12.007
Wang X., Wong K., Ouyang W., Rutz S. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases // Cold Spring Harb. Perspect. Biol. 2019. Vol. 11, № 2. Art. № a028548. DOI: 10.1101/cshperspect.a028548
Dhus O., Bunk S., von Aulock S., Hermann C. IL-10 Release Requires Stronger Toll-Like Receptor 4-Triggering Than TNF: A Possible Explanation for the Selective Effects of Heterozygous TLR4 Polymorphism Asp(299)Gly on IL-10 Release // Immunobiology. 2008. Vol. 213, № 8. P. 621–627. DOI: 10.1016/j.imbio.2008.03.001
References
Le G., Novotny S.A., Mader T.L., Greising S.M., Chan S.S.K., Kyba M., Lowe D.A., Warren G.L. A Moderate Oestradiol Level Enhances Neutrophil Number and Activity in Muscle After Traumatic Injury but Strength Recovery Is Accelerated. J. Physiol., 2018, vol. 596, no. 19, pp. 4665–4680. DOI: 10.1113/JP276432
Knyazeva L.I., Shishova A.S., Stepchenko M.A. Dinamika pokazateley immunnogo statusa i rigidnosti sosudistoy stenki u bol’nykh arterial’noy gipertenziey s ozhireniem [Dynamics of Indicators of the Immune Status and Rigidity of the Vascular Wall in Patients Suffering from Arterial Hypertension with Obesity]. Fundamental’nye issledovaniya, 2012, no. 7-2, pp. 338–343.
Giannakopoulou C.E., Sotiriou A., Dettoraki M., Yang M., Perlikos F., Toumpanakis D., Prezerakos G., Koutsourelakis I., Kastis G.A., Vassilakopoulou V., Mizi E., Papalois A., Greer J.J., Vassilakopoulos T. Regulation of Breathing Pattern by IL-10. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2019, vol. 317, no. 1, pp. R190–R202. DOI: 10.1152/ajpregu.00065.2019
Steensberg A., Febbraio M.A., Osada T., Schjerling P., Hall G., Saltin B., Pedersen B.K. Interleukin-6 Production in Contracting Human Skeletal Muscle Is Influenced by Pre-Exercise Glycogen Content. J. Physiol., 2001, vol. 537, no. 2, pp. 633–639. DOI: 10.1111/j.1469-7793.2001.00633.x
Snodgrass R.G., Boß M., Zezina E., Weigert A., Dehne N., Fleming I., Brüne B., Namgaladze D. Hypoxia Potentiates Palmitate-Induced Pro-Inflammatory Activation of Primary Human Macrophages. J. Biol. Chem., 2016, vol. 291, no. 1, pp. 413–424. DOI: 10.1074/jbc.M115.686709
Katinas E.B. Ryabova M.A., Karpishchenko S.A. Tsitokinovyy sostav laringeal’nogo sekreta u bol’nykh retsidiviruyushchim papillomatozom gortani pri mestnoy terapii interferonom al’fa-2 [Cytokine Composition of Laryngeal Secretion in Patients with Recurrent Laryngeal Papillomatosis at Local Therapy with Interferon Alfa-2]. Rossiyskiy immunologicheskiy zhurnal, 2008, vol. 2, no. 2, pp. 186–196.
Van Snick J. Interleukin-6: An Overview. Annu. Rev. Immunol., 1990, vol. 8, pp. 253–278. DOI: 10.1146/annurev.iy.08.040190.001345
Schwartz E.A., Zhang W.-Y., Karnik S.K., Borwege S., Anand V.R., Laine P.S., Su Y., Reaven P.D. Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation. Arterioscler. Thromb. Vasc. Biol., 2010, vol. 30, no. 4, pp. 802–808. DOI: 10.1161/ATVBAHA.109.201681
Titov V.N., Rozhkova T.A., Kaminnaya V.I. The Role of Excessive Meat Intake in the Pathogenesis of Atherosclerosis and Atheromatosis in Humans and Animals (Review). J. Med. Biol. Res., 2018, vol. 6, no. 2, pp. 174–187. DOI: 10.17238/issn2542-1298.2018.6.2.174
Titov V.N., Krylin V.V., Shiryaeva Yu.K. Profilaktika ateroskleroza. Izbytok v pishche pal’mitinovoy kisloty – prichina giperkholesterinemii, sindroma vospaleniya, rezistentnosti miotsitov k insulinu i apoptoza [Prevention of Atherosclerosis. Excess Palmitic Acid in Food Is a Cause of Hypercholesterolemia, Inflammatory Syndrome, Insulin Resistance in Myocytes, and Apoptosis]. Klinicheskaya laboratornaya diagnostika, 2011, no. 2, pp. 4–15.
Cury-Boaventura M.F., Gorjão R., Martins de Lima T., Fiamoncini J., Godoy A.B.P., Deschamphs F.C., Soriano F.G., Curi R. Effect of Medium/ω-6 Long Chain Triglyceride-Based Emulsion on Leucocyte Death and Inflammatory Gene Expression. Clin. Exp. Immunol., 2011, vol. 165, no. 3, pp. 383–392. DOI: 10.1111/j.1365-2249.2011.04432.x
Stavinskaya O.A., Balashova S.N. Uchastie leptina v regulyatsii programmiruemoy kletochnoy gibeli u lits s dislipidemiey [The Involvement of Leptin in the Regulation of Programmed Cell Death in Persons with Dyslipidemia]. Ekologiya cheloveka, 2015, no. 12, pp. 34–37.
Diaconu A., Coculescu B.I., Manole G., Vultur H., Coculescu E.C., Stocheci C.M., Tudorache I.S., Dincă A.L., Dincă V.G. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) – Possible Diagnostic and Risk Biomarker in Chronic Ischaemic Heart Disease. J. Enzyme Inhib. Med. Chem., 2021, vol. 36, no. 1, pp. 68–73. DOI: 10.1080/14756366.2020.1839447
Nezos A., Skarlis C., Psarrou A., Markakis K., Garantziotis P., Papanikolaou A., Gravani F., Voulgarelis M., Tzioufas A.G., Koutsilieris M., Moutsopoulos H.M., Kotsifaki E., Mavragani C.P. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma? Front. Immunol., 2021, vol. 12. Art. no. 683623. DOI: 10.3389/fimmu.2021.683623
Yazdi A.S., Ghoreschi K. The Interleukin-1 Family. Adv. Exp. Med. Biol., 2016, vol. 941, pp. 21–29. DOI: 10.1007/978-94-024-0921-5_2
Shin M.S., Kang Y., Lee N., Wahl E.R., Kim S.H., Kang K.S., Lazova R., Kang I. Self Double-Stranded (ds) DNA Induces IL-1β Production from Human Monocytes by Activating NLRP3 Inflammasome in the Presence of AntidsDNA Antibodies. J. Immunol., 2013, vol. 190, no. 4, pp. 1407–1415. DOI: 10.4049/jimmunol.1201195
Snodgrass R.G., Huang S., Namgaladze D., Jandali O., Shao T., Sama S., Brüne B., Hwang D.H. Docosahexaenoic Acid and Palmitic Acid Reciprocally Modulate Monocyte Activation in Part Through Endoplasmic Reticulum Stress. J. Nutr. Biochem., 2016, vol. 32, pp. 39–45. DOI: 10.1016/j.jnutbio.2016.01.010
Danilova G.A. Mekhanizmy deystviya interleykina-1β na tsentral’nuyu khemoretseptsiyu [Mechanisms of Interleukin-1β Action on Central Chemoreception]. XXII s”ezd Fiziologicheskogo obshchestva im. I.P. Pavlova [The 22nd Congress of I.P. Pavlov Physiological Society]. Volgograd, 2013, pp. 142–143.
Liu J., Cao L., Feng Y., Li Y., Li T. MiR-338-3p Inhibits TNF-α-Induced Lipogenesis in Human Sebocytes. Biotechnol. Lett., 2017, vol. 39, no. 9, pp. 1343–1349. DOI: 10.1007/s10529-017-2369-3
Montier Y., Lorentz A., Krämer S., Sellge G., Schock M., Bauer M., Schuppan D., Bischoff S.C. Central Role of IL-6 and MMP-1 for Cross Talk Between Human Intestinal Mast Cells and Human Intestinal Fibroblasts. Immunobiology, 2012, vol. 217, no. 9, pp. 912–919. DOI: 10.1016/j.imbio.2012.01.003
Ridker P.M., MacFadyen J.G., Glynn R.J., Bradwin G., Hasan A.A., Rifai N. Comparison of Interleukin-6, C-Reactive Protein, and Low-Density Lipoprotein Cholesterol as Biomarkers of Residual Risk in Contemporary Practice: Secondary Analyses from the Cardiovascular Inflammation Reduction Trial. Eur. Heart J., 2020, vol. 41, no. 31, pp. 2952–2961. DOI: 10.1093/eurheartj/ehaa160
Señarís R.M., Trujillo M.L., Navia B., Comes G., Ferrer B., Giralt M., Hidalgo J. Interleukin-6 Regulates the Expression of Hypothalamic Neuropeptides Involved in Body Weight in a Gender-Dependent Way. J. Neuroendocrinol., 2011, vol. 23, no. 8, pp. 675–686. DOI: 10.1111/j.1365-2826.2011.02158.x
Samodova A.V., Dobrodeeva L.K., Shtaborov V.A., Pashinskaya K.O. Vliyanie reaktsiy mozgovogo natriyureticheskogo peptida, irisina, endotelina 1 na sostoyanie immunnoy sistemy, rabotayushchikh na arkhipelage Shpitsbergen, v zavisimosti ot sroka prozhivaniya [Influence of Brain Natriuretic Peptide, Irisin and Endothelin-1 Reactions on the Immune System in Persons Working in the Svalbard Archipelago Depending on Duration of Stay]. Vestnik Kol’skogo nauchogo tsentra RAN, 2018, vol. 10, no. 3, pp. 87–92.
Wedell-Neergaard A.S., Lang Lehrskov L., Christensen R.H., Legaard G.E., Dorph E., Larsen M.K., Launbo N., Fagerlind S.R., Seide S.K., Nymand S., Ball M., Vinum N., Dahl C.N., Henneberg M., Ried-Larsen M., Nybing J.D., Christensen R., Rosenmeier J.B., Karstoft K., Pedersen B.K., Ellingsgaard H., Krogh-Madsen R. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial. Cell Metab., 2019, vol. 29, no. 4, pp. 844–855. DOI: 10.1016/j.cmet.2018.12.007
Wang X., Wong K., Ouyang W., Rutz S. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. Cold Spring Harb. Perspect. Biol., 2019, vol. 11, no. 2. Art. no. a028548. DOI: 10.1101/cshperspect.a028548
Dhus O., Bunk S., von Aulock S., Hermann C. IL-10 Release Requires Stronger Toll-Like Receptor 4-Triggering Than TNF: A Possible Explanation for the Selective Effects of Heterozygous TLR4 Polymorphism Asp(299)Gly on IL-10 Release. Immunobiology, 2008, vol. 213, no. 8, pp. 621–627. DOI: 10.1016/j.imbio.2008.03.001
